Legislation

The ordinance authorizes the City and County of San Francisco to settle a lawsuit for $135,000 related to an employment dispute involving Antoine Fisher, Jayel Whitted, and Tonya Lett. The lawsuit was filed in July 2019 and has now been resolved with this settlement.

Ordinance authorizing settlement of the lawsuit filed by Antoine Fisher, Jayel Whitted, and Tonya Lett against the City and County of San Francisco, et al., for $135,000; the lawsuit was filed on July 2, 2019, in San Francisco Superior Court, Case No. CGC 19-577331; entitled Antoine Fisher, et al., vs. City and County of San Francisco, et al.; the lawsuit involves an employment dispute.

This ordinance allows the Office of Economic and Workforce Development to place up to 300 banners each year for three years without paying fees, promoting the "Shop & Dine in the 49" campaign. It also confirms that the Planning Department's assessment complies with environmental regulations.

Ordinance waiving the banner fees under Public Works Code, Section 184.78, for the placement of up to 300 banners per year, for three years starting on November 20, 2021, by the Office of Economic and Workforce Development to publicize the City’s “Shop & Dine in the 49” campaign; and affirming the Planning Department’s determination under the California Environmental Quality Act.

This ordinance allows businesses to place signs on awnings or marquees in certain commercial and mixed-use districts, in addition to existing regulations for projecting signs. It also expands sign controls to more Neighborhood Commercial Districts and confirms compliance with environmental and planning regulations.

Ordinance amending the Planning Code to allow business signs on awnings or marquees in addition to projecting signs in various neighborhood commercial and residential-commercial districts, and in certain Chinatown mixed use districts; applying business sign controls to additional Neighborhood Commercial Districts; affirming the Planning Department’s determination under the California Environmental Quality Act; and making findings of consistency with the General Plan, and the eight priority policies of Planning Code, Section 101.1, and public necessity, convenience, and general welfare findings pursuant to Planning Code, Section 302.

This ordinance suspends the Cannabis Business Tax in San Francisco until December 31, 2022. It aims to provide financial relief to cannabis businesses during this period.

Ordinance amending the Business and Tax Regulations Code to suspend the imposition of the Cannabis Business Tax through December 31, 2022.

The ordinance allows the Office of Economic and Workforce Development to set standards for cannabis-related training programs focused on social equity and business development. It also extends the temporary operating period for medical cannabis dispensaries awaiting permit approval from 120 to between 150 and 180 days, with new requirements related to hiring practices and labor agreements.

Ordinance amending the Police Code to clarify that the Office of Economic and Workforce Development (“OEWD”) may establish standards governing the certification of cannabis-related pre-apprenticeship programs that relate to social equity training, license incubation processes, underserved community outreach programs, and business plan development training; and amending the Health Code to extend from 120 days to between 150 and 180 days the period for which the Director of the Office of Cannabis (“OOC”) may grant temporary authorization to medical cannabis dispensaries (“MCDs”) to continue operating while they wait for the OOC to process their applications for cannabis business permits (“Temporary MCD Authorization”), and to add as prerequisites to Temporary MCD Authorization: that the MCD has not been found to have violated health and safety standards developed by the Director to protect the health and safety of employees, neighbors, and customers; that OEWD has not made a determination, or has determined that the MCD ensures that 35% of its new hires shall be registered apprentices enrolled in an approved apprenticeship program if feasible; and for any MCD with ten or more employees, that OEWD has not made a determination, or has determined that the MCD has entered into or made good faith efforts to enter into a Labor Peace Agreement or a collective bargaining agreement with a Bona Fide Labor Organization.

This motion establishes the 2022 meeting schedule for the Board of Supervisors, canceling specific regular meetings and all meetings during designated breaks. It also modifies certain rules to improve the efficiency of the meeting schedule.

Motion establishing the 2022 Board of Supervisors Regular Meeting Schedule, pursuant to Board of Supervisors Rules of Order, Sections 4.2 and 4.2.1, by cancelling the Regular Board meetings of January 18, February 22, May 31, June 21, July 5, October 4, October 11, and November 22; and all Regular Board and Committee meetings during the spring, summer and winter breaks from March 28 through April 1, August 1 through September 5, and December 14, 2022 through January 6, 2023; and further suspending portions of Board Rule 4.2 to effectuate certain dates within the regular meeting schedule to augment the flow of business.

The ordinance allows the Mayor's Office to accept a $3,407,000 grant from Bloomberg Philanthropies and adds new staff positions funded by this grant. It includes one position in the Mayor's Office and four positions in the City Administrator's Office, effective from October 1, 2021, to August 31, 2024.

Ordinance retroactively authorizing the Office of the Mayor to accept and expend a grant in the amount of $3,407,000 from Bloomberg Philanthropies, and amending Ordinance No. 109-21 (Annual Salary Ordinance File No. 210644 for Fiscal Years (FYs) 2021-2022 and 2022-2023) to provide for the addition of one grant funded Class 0904 Mayoral Staff XVI position (FTE 1.0) at the Office of the Mayor, two grant funded Class 1043 Engineer positions (FTE 2.0) at the Office of the City Administrator, and two grant funded Class 1053 Senior Business Analyst positions (FTE 2.0) at the Office of the City Administrator, for the period of October 1, 2021, through August 31, 2024.

This resolution allows the Treasure Island Yacht Club to transfer its liquor license for selling beer, wine, and distilled spirits to its new location at One Avenue of the Palms. It has been determined that this transfer will benefit the public in San Francisco.

Resolution determining that the premise-to-premise transfer of a Type-51 non-profit club on-sale beer, wine, and distilled spirits liquor license to Treasure Island Yacht Club, Inc., to do business as The Treasure Island Yacht Club, located at One Avenue of the Palms, Building One, Suite 133 (District 6), will serve the public convenience or necessity of the City and County of San Francisco, in accordance with California Business and Professions Code, Section 23958.4.

This resolution approves the transfer of a liquor license for Bottle Bacchanal, a business at 4126-18 Street, to sell beer, wine, and distilled spirits. It also requests that the state impose specific conditions on the license to ensure it meets public needs.

Resolution determining the transfer of a Type-21 off-sale general beer, wine, and distilled spirits liquor license to Bottle Bacchanal, LLC, doing business as Bottle Bacchanal, located at 4126-18 Street (District 8), will serve the public convenience or necessity of the City and County of San Francisco, in accordance with California Business and Professions Code, Section 23958.4; and requesting that the California Department of Alcoholic Beverage Control impose conditions on the issuance of the license.

This motion approves the Mayor's choice to reappoint Al Perez to the Entertainment Commission, where he will serve until July 1, 2025. The motion has been passed by the city.

Motion approving the Mayor’s nomination for reappointment of Al Perez to the Entertainment Commission, for a term ending July 1, 2025.

This resolution encourages the San Francisco Federal Credit Union to work with the SFMTA to establish fair prices for taxi medallions, consider loan forgiveness for medallion holders, and implement other necessary reforms. It has been officially passed by the city.

Resolution urging the San Francisco Federal Credit Union to collaborate with the San Francisco Municipal Transportation Agency (SFMTA) on agreeable medallion prices, loan forgiveness for medallion holders, and other reforms.

This resolution allows the Office of Economic and Workforce Development to use a $500,000 grant to support an additional 100 workers in San Francisco who lost their jobs due to COVID-19. The funding comes from the North Valley Workforce Development Board and is intended to enhance the city's workforce development efforts until August 19, 2023.

Resolution retroactively authorizing the Office of Economic and Workforce Development to accept and expend a grant in the amount of $500,000 from the North Valley Workforce Development Board, a recipient of the grant award from United States Department of Labor for CAREER National Dislocated Worker Grant to expand San Francisco’s public workforce development system to respond to an additional 100 dislocated workers impacted by COVID-19 for the grant period of October 1, 2021, through August 19, 2023.

The ordinance authorizes the City and County of San Francisco to settle a lawsuit with Brendan Mannix for $225,000 related to an employment dispute. This settlement resolves the case that was filed in August 2018.

Ordinance authorizing settlement of the lawsuit filed by Brendan Mannix against the City and County of San Francisco for $225,000; the lawsuit was filed on August 16, 2018, in San Francisco Superior Court, Case No. CGC-18-568967; entitled Brendan Mannix v. City and County of San Francisco; the lawsuit involves an employment dispute.

This resolution allows San Francisco to operate and maintain two groundwater project wells on land owned by Daly City without paying a fee, effective until June 30, 2034. It also gives the General Manager of the San Francisco Public Utilities Commission the authority to sign necessary documents and make modifications related to this agreement.

Resolution approving and authorizing the execution of a No-Fee License with the City of Daly City for the operation and maintenance of two Groundwater Project Wells on land owned by the City of Daly City located at 377 and 370 South Park Plaza Drive, Daly City, San Mateo County, California; and authorizing the San Francisco Public Utilities Commission's General Manager to execute documents, make certain modifications, and take certain actions in furtherance of this Resolution, as defined herein, for a term to commence upon execution of the License through June 30, 2034.

This ordinance expands the definition of "interested party" to include City contractors and others who influence City officials, and it prohibits certain City officials from soliciting donations from these interested parties. It aims to enhance transparency and reduce potential conflicts of interest in government dealings.

Ordinance amending the Campaign and Governmental Conduct Code to expand the definition of interested party to include City contractors, persons seeking to influence City officers and employees, registered contact lobbyists, permit consultants, and to prohibit elected officials, department heads, commissioners, and designated employees from soliciting behested payments from interested parties.

This resolution approves the annual report for the Tourism Improvement District and Moscone Expansion District for the fiscal year 2019-2020, as required by state law. It ensures compliance with the management agreement between the district and the city.

Resolution receiving and approving the annual report for the Tourism Improvement District and Moscone Expansion District for Fiscal Year (FY) 2019-2020, submitted as required by the Property and Business Improvement District Law of 1994 (California Streets and Highways Code, Sections 36600, et seq.), Section 36650, and the District’s management agreement with the City, Section 3.4.

This resolution allows Ish's Community Market, also known as Evergreen Market, to obtain a liquor license for selling beer, wine, and spirits at their location on Mission Street. It also requests that the state impose specific conditions on the license to ensure it meets public needs.

Resolution determining that the transfer of a Type-21 off-sale general beer, wine, and distilled spirits liquor license to Ish's Community Market, Corp., doing business as Evergreen Market, located at 2539 Mission Street (District 9), will serve the public convenience or necessity of the City and County of San Francisco, in accordance with California Business and Professions Code, Section 23958.4; and requesting that the California Department of Alcoholic Beverage Control impose conditions on the issuance of the license.

This resolution approves the transfer of a liquor license for The Olympic Club at 524 Post Street, allowing them to sell beer, wine, and distilled spirits. It has been determined that this transfer will benefit the public in San Francisco.

Resolution determining that the transfer of a Type-21 off-sale general beer, wine, and distilled spirits liquor license to The Olympic Club, located at 524 Post Street (District 3), will serve the public convenience or necessity of the City and County of San Francisco, in accordance with California Business and Professions Code, Section 23958.4.

The ordinance authorizes a partial settlement of a lawsuit against three major opioid distributors, aiming to secure between $27 million and $50 million in abatement funds over 18 years. This lawsuit alleges that these companies contributed to the opioid crisis in San Francisco by distributing excessive amounts of opioids while ignoring legal obligations to monitor and report suspicious orders.

Ordinance authorizing the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against three large distributors of prescription opioids (AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation) for abatement funds in the range of $27 million to $50 million to be paid over 18 years; the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation created a public nuisance and violated the Unfair Competition Law and the False Advertising Laws by distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and report suspicious opioid orders as required by state and federal law.

The ordinance authorizes a partial settlement of a lawsuit against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, for $6 million to $11 million over nine years due to their role in the opioid crisis. The lawsuit alleges that they created a public nuisance and violated laws through deceptive marketing and distribution of opioids in San Francisco.

Ordinance authorizing the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11 million to be paid over 9 years; the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that Johnson and Johnson’s subsidiary, Janssen Pharmaceuticals, Inc., created a public nuisance and violated the Unfair Competition Law and the False Advertising Laws through deceptive marketing of opioids, manufacturing and distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and to report suspicious opioid orders as required by state and federal law.

This resolution expresses San Francisco's support for providing small businesses with notice and resources to help them comply with the Americans with Disabilities Act when facing lawsuits or violations. It also calls for more assistance and information to aid these businesses in meeting ADA requirements.

Resolution stating that the City and County of San Francisco supports notice and compliance opportunities for small businesses facing lawsuits or violations related to Americans with Disabilities Act accommodations; and calling for additional support, assistance, and information for Small Businesses to comply with the American with Disabilities Act.

This hearing addresses Muni's long-term service coverage and frequency issues, ensuring alignment with housing and regional plans while focusing on access for residents, seniors, and those with limited mobility. It requests reports from various city departments to assess these concerns.

Hearing regarding Muni Plans, long term issues of service coverage and frequency, policy consistency with the Housing Element, Plan Bay Area 2050, access and basic service to West Side residents, seniors, people with limited mobility, and those who live in areas with low ridership pre-pandemic; and requesting the Municipal Transportation Agency, Department of Disability and Aging Services, Planning Department, County Transportation Authority, Office of Economic and Workforce Development, and the Office of Resilience and Capital Planning to report.

The ordinance updates the Local Business Enterprise (LBE) and Non-Discrimination in Contracting rules to raise certification size limits, increase penalties for violations, and improve payment timelines for subcontractors. It also introduces new programs to support small businesses and raises certain contracting thresholds.

Ordinance amending the Administrative Code to revise the Local Business Enterprise (LBE) and Non-Discrimination in Contracting Ordinance (Chapter 14B) to: 1) increase the LBE certification size thresholds and authorize an automatic increase to the thresholds every five years based on the consumer price index; 2) change the LBE certification size threshold term of calculation from an average of gross annual receipts in the prior three to the prior five years; 3) increase penalties for violations of Chapter 14B from up to 10% to up to 25% of the contract or subcontract amount; 4) require prime contractors to include LBE subcontractors’ approved payment requests in payment applications within 30 days of receipt of an invoice; 5) authorize application of separate LBE subcontract participation requirements for micro, small, and SBA-LBEs; 6) extend the bonding assistance program to certain City-funded construction projects; 7) authorize a pilot Mentor-Protégé expansion program, a pilot micro-LBE set-aside program for certain design-build and construction manager/general contractor projects, and a pilot Neighborhood LBE program; and 8) increase the contracting Threshold Amount from $706,000 to $1,000,000 and the Minimum Competitive Amount from $129,000 to $200,000; and make various other changes and clarifications to Chapter 14B, as defined herein.

This ordinance allows bars to operate in the Castro Street Neighborhood Commercial District under certain conditions. It also confirms that this decision aligns with environmental regulations and city planning policies.

Ordinance amending the Planning Code to conditionally permit Bars in the Castro Street Neighborhood Commercial District; affirming the Planning Department’s determination under the California Environmental Quality Act; making findings of consistency with the General Plan, and the eight priority policies of Planning Code, Section 101.1.; and making findings of public necessity, convenience, and welfare under Planning Code, Section 302.

This legislation calls for a hearing to discuss the need for workforce housing in San Francisco, focusing on affordability and stability for workers across various income levels. It aims to evaluate current development policies and their impact on housing costs, while requesting a report from the Planning Department.

Hearing on the City's need to address workforce housing, across the full range of worker incomes as identified in Jobs-Housing Fit reports, including new and strengthened policies to support housing affordability and stability, provide affordable housing at a mix of incomes, and curb speculation, gentrification, and displacement; and how the City's development policies promote or obstruct the fit between wages and housing costs; and requesting the Planning Department to report.

This hearing is to provide a six-month update on the implementation of new consumer protection measures in the Building Code, which include creating and publishing a list of compliance issues and notifying relevant parties about these issues. The Department of Building Inspection and the City Attorney's Office will report on the progress of these provisions.

Hearing regarding a six-month status update on the implementation of Expanded Compliance Control and Consumer Protection provisions per Building Code amendments enacted March 26, 2021, including but not limited to creating the Expanded Compliance Control list, reporting on the list to the Building Inspection Commission, referring listees to state licensing boards, publication of the list on the Department of Building Inspection website, and notifying all parties listed on a permit application associated that includes a listee; and requesting the Department of Building Inspection and Office of the City Attorney to report.

This ordinance reallocates $400,000 from the Legacy Business Historic Preservation Fund to create a new grant program for Legacy Businesses in the 2021-2022 fiscal year. It aims to support these businesses through financial assistance.

Ordinance de-appropriating $400,000 previously appropriated to the Office of Economic and Workforce Development (ECN) for the Office of Small Business’ Legacy Business Historic Preservation Fund and re-appropriating $400,000 to ECN to provide a new grant program for Legacy Businesses in Fiscal Year (FY) 2021-2022.

The ordinance authorizes a payment of $580,000 to settle the City’s claim for attorney’s fees and costs related to a lawsuit filed by Contest Promotions, LLC regarding compliance with a previous settlement and the constitutionality of certain Planning Code sections. This lawsuit was consolidated from two cases filed in 2015 and 2016.

Ordinance authorizing settlement by payment of $580,000 to the City and County of San Francisco, of the City’s claim for attorney’s fees and costs arising from the lawsuit that Contest Promotions, LLC filed against the City; the lawsuit was filed on August 26, 2015, in San Francisco Superior Court, Case No. CGC-15-547630; entitled Contest Promotions, LLC vs. City and County of San Francisco; San Francisco Superior Court Case No. CPF-16-514771 was filed on February 9, 2016, and the actions were consolidated; the lawsuit involves a dispute about the City’s compliance with a prior settlement agreement between the parties, and the constitutionality of sections of the Planning Code regulating on-site and off-site commercial signs.

This ordinance extends various deadlines related to Medical Cannabis Dispensaries and Cannabis Retail Use in San Francisco, pushing them from 2021 to 2022 and 2023. It also allows for the extension of Temporary Cannabis Business Permits and the Cannabis Event Permit pilot program.

Ordinance amending the Health Code, Planning Code, and Police Code to extend the sunset date for provisions governing Medical Cannabis Dispensaries from December 31, 2021, to December 31, 2022; to extend the sunset date for allowing the conversion of Medical Cannabis Dispensaries with Planning Commission approval to a Cannabis Retail Use from January 1, 2022, to January 1, 2023; to allow the extension of Temporary Cannabis Business Permits for additional 120-day terms through December 31, 2022, rather than December 31, 2021; and to allow the extension of the Cannabis Event Permit pilot program through December 31, 2023, rather than December 31, 2021; affirming the Planning Department’s determination under the California Environmental Quality Act; and making findings of consistency with the General Plan, and the eight priority policies of Planning Code, Section 101.1.

This ordinance repeals the City Employee’s Sexual Privacy Ordinance and requires the Department of Human Resources to ask job applicants and employees to voluntarily share their sexual orientation and gender identity information for demographic purposes. It also mandates the development of systems to collect and keep this information confidential.

Ordinance amending the Administrative Code to repeal the City Employee’s Sexual Privacy Ordinance; direct the Department of Human Resources (DHR) to request that applicants for City employment voluntarily provide sexual orientation and gender identity information; direct City departments to request that employees voluntarily provide anonymous sexual orientation and gender identity information when responding to surveys that also seek other demographic information; and direct DHR to develop systems for voluntary collection and confidential retention of sexual orientation and gender identity information.

This ordinance extends the existence of the Cannabis Oversight Committee until January 1, 2025. It amends the Administrative Code to reflect this new sunset date.

Ordinance amending the Administrative Code to extend the sunset date for the Cannabis Oversight Committee from December 3, 2021, to January 1, 2025.

This resolution allows the Department of Public Health to accept and use a donation of software licenses for an ophthalmology application valued at nearly $60,000, which will support eye care services until June 2025. The donation comes from the San Francisco General Hospital Foundation.

Resolution retroactively authorizing the Department of Public Health to accept and expend an in-kind gift of perpetual software licenses of the ZEISS forum ophthalmology application valued in the amount of $59,949 from the San Francisco General Hospital Foundation for the Department of Public Health to provide eye care and eye disease management for the project period of July 8, 2016, through June 16, 2025.

This resolution approves a payment of $59,000 to Sandeep Lal to settle an employment dispute claim against the City and County of San Francisco. The claim was originally filed in December 2019 and November 2020.

Resolution approving the settlement of the unlitigated claim filed by Sandeep Lal against the City and County of San Francisco for $59,000; the claim was filed December 6, 2019, and November 17, 2020; the claim involves an employment dispute.

The legislation involves a public hearing to discuss proposed ordinances related to a partial settlement of lawsuits against major opioid distributors and manufacturers, seeking abatement funds totaling between $33 million and $61 million over several years. This hearing is scheduled for November 2, 2021, at 3:00 p.m.

Hearing of the Board of Supervisors sitting as a Committee of the Whole on November 2, 2021, at 3:00 p.m., to hold a public hearing to consider the proposed Ordinances (File Nos. 211071 and 211072) regarding existing litigation relating to the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against three large distributors of prescription opioids (AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation) for abatement funds in the range of $27 million to $50 million to be paid over 18 years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; and the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11 million to be paid over nine years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; scheduled pursuant to Motion Nos. M21-148 (File No. 211112) and M21-149 (File No. 211114), approved on October 26, 2021.

This legislation allows the San Francisco Board of Supervisors to hold a closed session to discuss legal advice regarding ongoing lawsuits against major opioid distributors and manufacturers, seeking settlement funds for the city. The lawsuits aim to secure between $27 million to $50 million and $6 million to $11 million in abatement funds to address the opioid crisis over specified timeframes.

Closed Session for the Board of Supervisors to convene on November 2, 2021, pursuant to California Government Code, Section 54956.9, and San Francisco Administrative Code, Section 67.10(d)(1), for the purpose of conferring with, or receiving advice from the City Attorney regarding existing litigation relating to the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against three large distributors of prescription opioids (AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation) for abatement funds in the range of $27 million to $50 million to be paid over 18 years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation (File No. 211071); and the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11 million to be paid over nine years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation (File No. 211072); scheduled pursuant to Motion Nos. M21-148 (File No. 211112) and M21-149 (File No. 211114), approved on October 26, 2021.